Pharmaceutical master validation plan : the ultimate guide to FDA, GMP, and GLP compliance / Syed Imtiaz Haider.
Material type:
TextLanguage: English Publication details: Boca Raton : St. Lucie Press, c2002. Description: xxxi, 176 p. : ill. ; 25 cm. +ISBN: 1574443305 (alk. paper); 9781574443301Subject(s): Pharmaceutical technology -- Quality control | Pharmaceutical industry -- Quality control | Drug Industry -- standardsDDC classification: 615.19021873 LOC classification: RS192 | .H3533 2002NLM classification: QV 736Online resources: WorldCat details | Ebook Fulltext | Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|---|---|
E-Book
|
Dr. S. R. Lasker Library, EWU E-book | Non-fiction | 615.19021873 HAP 2002 (Browse shelf(Opens below)) | Not for loan | ||||
CDs & DVDs
|
Dr. S. R. Lasker Library, EWU Audio Visual | Non-fiction | 615.19021873 HAP 2002 (Browse shelf(Opens below)) | C-1 | Available | CD-1153 | ||
Text
|
Dr. S. R. Lasker Library, EWU Reserve Section | Non-fiction | 615.19021873 HAP 2002 (Browse shelf(Opens below)) | C-1 | Not For Loan | 19465 | ||
|
CDs & DVDs
|
Dr. S. R. Lasker Library, EWU Audio Visual | Non-fiction | 615.19021873 HAP 2002 (Browse shelf(Opens below)) | C-2 | Available | CD-1154 | ||
|
Text
|
Dr. S. R. Lasker Library, EWU Circulation Section | Non-fiction | 615.19021873 HAP 2002 (Browse shelf(Opens below)) | C-2 | Available | 19466 | ||
|
CDs & DVDs
|
Dr. S. R. Lasker Library, EWU Audio Visual | Non-fiction | 615.19021873 HAP 2002 (Browse shelf(Opens below)) | C-3 | Available | CD-1155 | ||
|
Text
|
Dr. S. R. Lasker Library, EWU Circulation Section | Non-fiction | 615.19021873 HAP 2002 (Browse shelf(Opens below)) | C-3 | Available | 19467 | ||
|
Text
|
Dr. S. R. Lasker Library, EWU Circulation Section | Non-fiction | 615.19021873 HAP 2002 (Browse shelf(Opens below)) | C-4 | Available | 20049 | ||
|
CDs & DVDs
|
Dr. S. R. Lasker Library, EWU Audio Visual | Non-fiction | 615.19021873 HAP 2002 (Browse shelf(Opens below)) | C-4 | Available | CD-1156 | ||
|
Text
|
Dr. S. R. Lasker Library, EWU Circulation Section | Non-fiction | 615.19021873 HAP 2002 (Browse shelf(Opens below)) | C-5 | Available | 20050 | ||
|
CDs & DVDs
|
Dr. S. R. Lasker Library, EWU Audio Visual | Non-fiction | 615.19021873 HAP 2002 (Browse shelf(Opens below)) | C-5 | Available | CD-1157 |
Browsing Dr. S. R. Lasker Library, EWU shelves, Shelving location: Audio Visual Close shelf browser (Hides shelf browser)
|
|
|
|
|
|
|
||
| 615.19 BUR 2003 Burger's medicinal chemistry and drug discovery / | 615.19 BUR 2003 Burger's medicinal chemistry and drug discovery / | 615.19 BUR 2003 Burger's medicinal chemistry and drug discovery / | 615.19021873 HAP 2002 Pharmaceutical master validation plan : | 615.19021873 HAP 2002 Pharmaceutical master validation plan : | 615.19021873 HAP 2002 Pharmaceutical master validation plan : | 615.19021873 HAP 2002 Pharmaceutical master validation plan : |
Includes bibliographical references and index.
TOC Validation master plan approval page --
1. Introduction --
2. Concept of qualification/validation --
3. Revalidation --
4. Facility description --
5. Description of building --
6. Equipment description --
7. HVAC description --
8. Utilities descriptions --
9. Validation program overview --
10. Calibration program summary --
11. Preventive maintenance program summary --
12. Key standard operating procedures (SOPs) --
13. Validation of building --
14. Validation of utility systems --
15. Process description for dry production facility: Building A --
16. Process description for liquid and semisolid production facility: Building B --
17. Process description for parenterals production facility: Building C --
18. Qualification of process equipment --
19. Validation of support processes --
20. Quality assurance/control laboratory validation --
21. cGMP procedures and programs --
22. Validation schedule --
23. Drawings for ABC pharmaceutical plant.
Summary:
This text provides the tools to minimize non-conformance, reduce rework and rejected lots, avoid recall lots, and more easily achieve new drug approval, satisfactory inspections, corporate legal Read more...
Pharmacy
Saifun Momota
There are no comments on this title.